SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001437749-18-001781
Filing Date
2018-02-06
Accepted
2018-02-06 11:54:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 8-K avir20180206_8k.htm 425 37877
2 EXHIBIT 99.1 ex_104404.htm EX-99.1 20350
3 aviragen_logo.jpg GRAPHIC 5881
  Complete submission text file 0001437749-18-001781.txt   68664
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Filed by) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 425 | Act: 34 | File No.: 001-35285 | Film No.: 18576745
SIC: 2836 Biological Products, (No Diagnostic Substances)